Niigata, Japan

Shoji Kuwahara

This inventor holds 1 USPTO granted patent. Top assignees: Ea Pharma Co., Ltd., Niigata University. Active years: 2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Shoji Kuwahara. Retrieved from https://idiyas.com/inventor/shoji-kuwahara

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1


Company Filing History:


Years Active: 2019

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Shoji Kuwahara

Introduction

Shoji Kuwahara is a notable inventor based in Niigata, Japan. He has made significant contributions to the field of pharmaceuticals, particularly in the area of renal impairment and inner ear disorders. His work has the potential to impact many lives through innovative medical solutions.

Latest Patents

Kuwahara holds a patent for a megalin antagonist. This invention includes cilastatin or a pharmaceutically acceptable salt as an active component. It serves as a suppressant for renal impairment or inner ear disorders induced via megalin by at least one megalin ligand. The ligands selected for this invention include polymyxins, aminoglycoside antibiotics, glycopeptide antibiotics, cisplatin, and their pharmaceutically acceptable salts. He has 1 patent to his name.

Career Highlights

Throughout his career, Kuwahara has worked with prominent organizations such as Ea Pharma Co., Ltd. and Niigata University. His experience in these institutions has allowed him to develop and refine his innovative ideas in the pharmaceutical sector.

Collaborations

Kuwahara has collaborated with esteemed colleagues, including Yoshihisa Hori and Hiroshi Iwata. These partnerships have contributed to the advancement of his research and the successful development of his inventions.

Conclusion

Shoji Kuwahara's contributions to the field of pharmaceuticals demonstrate his commitment to innovation and improving healthcare solutions. His work continues to inspire future advancements in medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…